EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrating PSA Change with PSA Density Enhances Diagnostic Accuracy and Helps Avoid Unnecessary Prostate Biopsies

Yi-Ju Chou iD, Bor-En Jong, Yao-Chou Tsai iD

Diagnostics · 13.08.2025 · 15 (16) · 2027

DOI: 10.3390/diagnostics15162027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 13.08.2025. Verfasst von Yi-Ju Chou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Urology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei 231, Taiwan. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Prostate-specific antigen (PSA) levels can be transiently elevated in benign conditions. Therefore, guidelines recommend repeat PSA testing before a biopsy. However, PSA should be adjusted for the prostate volume to improve its predictive accuracy for prostate cancer. This study aimed to compare the diagnostic performance of the PSA density and PSA change for prostate cancer and to evaluate whether their combination can further reduce unnecessary biopsies.

Methods

We retrospectively analyzed patients who underwent a prostate biopsy between January 2020 and December 2024. Inclusion criteria were an initial PSA level between 3 and 20 ng/mL and two PSA measurements within an eight-week interval prior to the biopsy. Patients using 5-alpha reductase inhibitors before the biopsy were excluded. Receiver operating characteristic (ROC) curves and the area under the curve (AUC) were used to compare the diagnostic performance of each predictor for prostate cancer and clinically significant prostate cancer (csPCa).

Results

A total of 291 patients were included. Patients with prostate cancer had higher PSA levels, smaller PSA declines, and a higher PSA density. The PSA density showed a superior diagnostic accuracy compared with the PSA change for both prostate cancer and csPCa. The PSA density calculated by a transrectal ultrasound or MRI yielded a similar diagnostic performance. However, the accuracy of the PSA density decreased in patients with a large prostate volume. Incorporating a criterion of a >20% PSA decline to exclude biopsy candidates improved the performance of the PSA density and further reduced unnecessary biopsies.

Conclusions

The PSA density demonstrates good diagnostic accuracy for predicting prostate cancer. However, incorporating the PSA change further reduces unnecessary biopsies. Therefore, combining both factors provides a more effective approach for determining the need for a prostate biopsy.

Schlagwörter

Stichwörter der Autor:innen

PSAPSA densityprostate cancer

Autor:innen und Institutionen

  • Division of Urology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei 231, Taiwan.
  • School of Medicine, Tzu Chi University, Hualien 970, Taiwan.

ORCID-Profile: Yi-Ju Chou, Yao-Chou Tsai

Zitieren

APA

Chou, Y. J., Jong, B. E., & Tsai, Y. C. (2025). Integrating PSA Change with PSA Density Enhances Diagnostic Accuracy and Helps Avoid Unnecessary Prostate Biopsies. Diagnostics, 15(16), 2027. https://doi.org/10.3390/diagnostics15162027

Vancouver

Chou YJ, Jong BE, Tsai YC. Integrating PSA Change with PSA Density Enhances Diagnostic Accuracy and Helps Avoid Unnecessary Prostate Biopsies. Diagnostics. 2025;15(16):2027. doi:10.3390/diagnostics15162027

BibTeX
@article{Chou2025,
  author = {Chou, Yi-Ju and Jong, Bor-En and Tsai, Yao-Chou},
  title = {Integrating PSA Change with PSA Density Enhances Diagnostic Accuracy and Helps Avoid Unnecessary Prostate Biopsies},
  journal = {Diagnostics},
  year = {2025},
  volume = {15},
  number = {16},
  pages = {2027},
  doi = {10.3390/diagnostics15162027}
}
Kostenlos starten →